Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank29
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-66.42M
↓ 25% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-53.32M
Historical baseline
PeriodValueYoY Change
TTM$-66.42M+42.5%
2024$-115.55M+15.0%
2023$-135.89M-118.9%
2022$-62.09M-349.1%
2021$-13.83M+48.4%
2020$-26.81M-474.1%
2019$-4.67M-254.1%
2018$-1.32M-